S&P SmallCap 600 Pure Growth Fund PTGX Holdings History
S&P SmallCap 600 Pure Growth Fund's Protagonist Therapeutics Inc Holding Summary
As of 2025-03-31, RYDEX SERIES FUNDS held 1,324.00 shares of Protagonist Therapeutics Inc(PTGX), totaling $64,030.00. This investment constitutes 1.98% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0% of the outstanding Protagonist Therapeutics Inc(PTGX) stock.
The initial trade took place in 2024Q4. And since then S&P SmallCap 600 Pure Growth Fund has made 1 purchases of PTGX, at an average price of $43.59, for a total of 1,522.00 shares. In addition, there have been 1 sales at an average price of $41.90 for 198.00 shares. Based on historical transaction data and PTGX's current price of $55.48, S&P SmallCap 600 Pure Growth Fund's estimated gain on his PTGX holdings is $15,407.74, reflecting a 23.22% gain to date.
S&P SmallCap 600 Pure Growth Fund PTGX ($55.48) Holding Chart
S&P SmallCap 600 Pure Growth Fund PTGX ($55.48) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
